Medexus Pharmaceuticals Inc (MDP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,062 | 3,887 | 5,024 | 3,807 | 2,415 |
| Receivables | 554 | 585 | 302 | 231 | 336 |
| Inventories | 1,183 | 851 | 653 | 470 | 462 |
| TOTAL | $4,856 | $5,414 | $6,047 | $4,548 | $3,238 |
| Non-Current Assets | |||||
| PPE Net | 21 | 25 | 27 | 31 | 33 |
| Intangibles | 1,443 | 1,324 | 1,302 | 1,317 | 1,171 |
| TOTAL | $1,463 | $1,349 | $1,329 | $1,348 | $1,204 |
| Total Assets | $6,319 | $6,763 | $7,375 | $5,896 | $4,442 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 0 | 1 |
| Accounts payable and accrued liabilities | 985 | 682 | 799 | 270 | 800 |
| Accrued Expenses | 125 | 130 | 129 | 450 | 122 |
| TOTAL | $1,110 | $812 | $928 | $721 | $923 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,133 | 3,123 | 3,096 | 3,013 | 2,675 |
| TOTAL | $3,133 | $3,123 | $3,096 | $3,013 | $2,675 |
| Total Liabilities | $4,244 | $3,934 | $4,024 | $3,734 | $3,598 |
| Shareholders' Equity | |||||
| Retained earnings | -16,519 | -16,091 | -15,704 | -16,764 | -16,789 |
| TOTAL | $2,076 | $2,828 | $3,352 | $2,162 | $844 |
| Total Liabilities And Equity | $6,319 | $6,763 | $7,375 | $5,896 | $4,442 |